Search results
Author(s):
Khaled Elenizi
,
Rasha Alharthi
Added:
8 months ago
Author(s):
Angelo Auricchio
,
Anne B Curtis
Added:
1 year ago
Prof Anne Curtis (University of Buffalo, US) and Prof Angelo Auricchio (Fondazione Cardiocentro Ticino, CH) discuss contemporary clinical data of Implantable Cardioverter Defibrillators (ICDs) from real world populations. The discussion is focused on the importance and impact of ICD therapy on prevention of sudden cardiac death by analysing the latest presented data.In context, the data analysed…
View more
Author(s):
Blandine Mondésert
,
Pier D Lambiase
,
Lluis Mont
,
et al
Start date:
Oct 23, 2024
This session covers the latest data on transvenous and subcutaneous ICD devices, focusing on shared decision-making and their practical applications in preventing sudden cardiac death. Moderated by Dr Blandine Mondésert (Montreal Heart Institute and University of Montreal, CA) and Dr Ulrika Birgersdotter-Green (University of California San Diego, US), this webinar delves into the long-term…
View more
Author(s):
Paul Foley
,
Honey Thomas
,
Mark Dayer
,
et al
Added:
1 year ago
Author(s):
Valentina Kutyifa
Added:
2 months ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of…
View more
Author(s):
Elaine Wan
,
Majd Al Deen Alhuarrat
Added:
1 year ago
In the latest episode of Arrhythmia Academy's Journal Club, Dr Elaine Wan (Columbia University, New York, NY, US) and Dr Majd Al Deen Alhuarrat (Albert Einstein College of Medicine, New York, NY, US) discuss the in-hospital outcomes and complications of using leadless pacemakers and traditional transvenous pacemakers.Dr Alhuarrat provides a concise history and background of transvenous and…
View more
Author(s):
Michal Droppa
,
Tobias Geisler
,
Jan Baan
,
et al
Added:
2 weeks ago
Added:
4 months ago
Source:
Arrhythmia Academy
AUTHOR: David RamseyLeading cardiovascular societies have unveiled an updated appropriate use criteria (AUC) document redefining clinical decision-making for cardiac implantable devices. The practice guideline entitled "ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing" was published online…
View more
Author(s):
Added:
2 months ago
EHRA 2025 - Long-term insights from pacemaker implantation after transcatheter aortic valve implantation (TAVI) show patients receiving pacemaker therapy within 30 days after TAVI had a significantly worse prognosis compared to patients with no pacemaker therapy in regards to all-cause death and CV death at one, five and ten year follow-ups.Prof Patrick Badertscher (University Hospital Basel,…
View more
Author(s):
David Duncker
,
Christopher Aldo Rinaldi
Added:
1 year ago
In this episode of the Arrhythmia Academy Journal Club, Prof David Duncker (Hannover Heart Rhythm Center, DE) is joined by Prof Aldo Rinaldi (Guy's and St Thomas' NHS Foundation Trust, UK) to discuss right atrium targeting for leadless atrial pacemaker implantation.Prof Rinaldi presents a background of this technology, as well as data in regard to the implantation of this atriovenous pacemaker…
View more